Antiviral Drug Resistance Market Size, Share, and Forecast by 2031
Antiviral Drug Resistance Market: Strategic Insights
Antiviral Drug Resistance Market
-
CAGR (2023 - 2031)7.9% -
Market Size 2023
US$ 3.44 Billion -
Market Size 2031
US$ 6.35 Billion
Market Dynamics
GROWTH DRIVERS
- Risisng Incidences of Hepatatic Diseases to Favor Market
FUTURE TRENDS
- Increasing Prevalence of HIV/AIDs
OPPORTUNITIES
- Increasing Healthcare Expenditures in Emerging Markets
Key Players
- AccuBioTech Co Ltd
- ACON Laboratories Inc
- Siemens AG
- BioM rieux SA
- Bio Rad Laboratories Inc
- Danaher
- Abbott
- BD
- F Hoffmann La Roche Ltd
- Trinity Biotech
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
Product
- Kits & Reagents
- Instruments
Disease Indication
- Human Immunodeficiency Virus
- Hepatitis
- Cytomegalovirus
Technology
- Immunodiagnostics
- Polymerase Chain Reaction
- Next Generation Sequencing
- Other Technologies
End User
- Hospitals & Clinics
- Pathology or Diagnostic Laboratories
- Research Institutes